Identification of lung adenocarcinoma subtypes and predictive signature for prognosis, immune features, and immunotherapy based on immune checkpoint genes
Background: Lung adenocarcinoma (LUAD) is the most common variant of non–small cell lung cancer (NSCLC) across the world. Recently, the rapid development of immunotherapy has brought a new dawn for LUAD patients. Closely related to the tumor immune microenvironment and immune cell functions, more an...
שמור ב:
| Principais autores: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Frontiers Media S.A.
2023-05-01
|
| סדרה: | Frontiers in Cell and Developmental Biology |
| נושאים: | |
| גישה מקוונת: | https://www.frontiersin.org/articles/10.3389/fcell.2023.1060086/full |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
